BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 29021002)

  • 1. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
    Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z
    Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling.
    Ye J; Chen W; Wu ZY; Zhang JH; Fei H; Zhang LW; Wang YH; Chen YP; Yang XM
    Oncol Rep; 2016 Dec; 36(6):3588-3596. PubMed ID: 27779718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β1 pathway.
    Chen CH; Shyu MK; Wang SW; Chou CH; Huang MJ; Lin TC; Chen ST; Lin HH; Huang MC
    Gynecol Oncol; 2016 Jan; 140(1):131-7. PubMed ID: 26616226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells.
    Park EH; Kim S; Jo JY; Kim SJ; Hwang Y; Kim JM; Song SY; Lee DK; Koh SS
    Carcinogenesis; 2013 Mar; 34(3):694-702. PubMed ID: 23222813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
    Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
    Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway.
    Li LY; Yin KM; Bai YH; Zhang ZG; Di W; Zhang S
    Clin Exp Metastasis; 2019 Aug; 36(4):351-363. PubMed ID: 31119444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of integrin beta3-FAK signaling pathway activated by osteopontin inhibits neointimal formation after balloon injury.
    Han M; Wen JK; Zheng B; Liu Z; Chen Y
    Cardiovasc Pathol; 2007; 16(5):283-90. PubMed ID: 17868879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis.
    Mei D; Zhu Y; Zhang L; Wei W
    Mediators Inflamm; 2020; 2020():9578701. PubMed ID: 32848510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin expression in epithelial ovarian cancers and promotes HO8910 cell migration associated with upregulating integrin α5β1 and phosphorylating FAK and paxillin.
    Deng B; Zhang S; Miao Y; Han Z; Zhang X; Wen F; Zhang Y
    J Exp Clin Cancer Res; 2012 Mar; 31(1):19. PubMed ID: 22400488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
    Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
    J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer.
    Peng J; Yang X; Li X; Gao H; Liu N; Guo X
    Cell Cycle; 2019 Aug; 18(16):1925-1937. PubMed ID: 31290719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillar type I collagen matrices enhance metastasis/invasion of ovarian epithelial cancer via β1 integrin and PTEN signals.
    Shen Y; Shen R; Ge L; Zhu Q; Li F
    Int J Gynecol Cancer; 2012 Oct; 22(8):1316-24. PubMed ID: 23013730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway.
    Zhang P; Zhang H; Wang Y; Zhang P; Qi Y
    Med Sci Monit; 2019 May; 25():3366-3373. PubMed ID: 31062766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Collagen Triple Helix Repeat Containing 1 Overexpression With Lymph Node and Peritoneal Metastasis in Epithelial Ovarian Cancer.
    Yang C; Liu T; Xia B; Gu L; Lou G
    Int J Gynecol Cancer; 2017 Jan; 27(1):22-27. PubMed ID: 27870703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.
    Huang B; Yin M; Li X; Cao G; Qi J; Lou G; Sheng S; Kou J; Chen K; Yu B
    Oncotarget; 2016 May; 7(19):27552-66. PubMed ID: 27050277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrins and haptoglobin: Molecules overexpressed in ovarian cancer.
    Villegas-Pineda JC; Garibay-Cerdenares OL; Hernández-Ramírez VI; Gallardo-Rincón D; Cantú de León D; Pérez-Montiel-Gómez MD; Talamás-Rohana P
    Pathol Res Pract; 2015 Dec; 211(12):973-81. PubMed ID: 26549463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.